Shailendra Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shailendra Singh has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Christopher E. Brightling
Institute for Lung Health, National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, UK
2 shared publications - Ruth Saunders
The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK
2 shared publications A. Sutcliffe
Institute for Lung Health Department of Infection, Immunity and Inflammation University of Leicester Leicester UK
1 shared publication- Antonella De Angelis
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
1 shared publication - Ashok Kumar
Department of Electronics & Communication, NITTTR , Chandigarh, India
1 shared publication - Bruno D'Agostino
Affiliation Department of Experimental Medicine L. Donatelli, Section of Pharmacology, School of Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
1 shared publication
Latest Publications
- Open Access
- 6 March 2016
- Published by Wiley in British Journal of Pharmacology
- Vol. 173 (8) , 1286-1301
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
Background and Purpose: There is evidence supporting a role for the nociceptin/orphanin FQ (N/OFQ; NOP) receptor and its endogenous ligand N/OFQ in the modulation of neurogenic inflammation, airway tone and calibre. We hypothesized that NOP receptor activation has beneficial effects upon asthma immunopathology and airway hyperresponsiveness. Therefore, the expression and function of N/OFQ and the NOP receptor were examined in healthy and asthmatic human airway tissues. The concept was further addressed in an animal model of allergic asthma.Experimental Approach: NOP receptor expression was investigated by quantitative real‐time PCR. Sputum N/OFQ was determined by RIA. N/OFQ function was tested using several assays including proliferation, migration, collagen gel contraction and wound healing. The effects of N/OFQ administrationin vivowere studied in ovalbumin (OVA)‐sensitized and challenged mice.Key Results: NOP receptors were expressed on a wide range of human and mouse immune and airway cells. Eosinophils expressed N/OFQ‐precursor mRNA and their number correlated with N/OFQ concentration. N/OFQ was found in human sputum and increased in asthma. Additionally, in asthmatic human lungs N/OFQ immunoreactivity was elevated. NOP receptor activation inhibited migration of immunocytes and increased wound healing in airway structural cells. Furthermore, N/OFQ relaxed spasmogen‐stimulated gel contraction. Remarkably, these findings were mirrored in OVA‐mice where N/OFQ treatment before or during sensitization substantially reduced airway constriction and immunocyte trafficking to the lung, in particular eosinophils. N/OFQ also reduced inflammatory mediators and mucin production.Conclusions and Implications: We demonstrated a novel dual airway immunomodulator/bronchodilator role for N/OFQ and suggest targeting this system as an innovative treatment for asthma.
- 6 March 2016
- Published by Wiley in British Journal of Pharmacology
- Vol. 173 (8) , 1286-1301
Open AccessNociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
Background and Purpose: There is evidence supporting a role for the nociceptin/orphanin FQ (N/OFQ; NOP) receptor and its endogenous ligand N/OFQ in the modulation of neurogenic inflammation, airway tone and calibre. We hypothesized that NOP receptor activation has beneficial effects upon asthma immunopathology and airway hyperresponsiveness. Therefore, the expression and function of N/OFQ and the NOP receptor were examined in healthy and asthmatic human airway tissues. The concept was further addressed in an animal model of allergic asthma.Experimental Approach: NOP receptor expression was investigated by quantitative real‐time PCR. Sputum N/OFQ was determined by RIA. N/OFQ function was tested using several assays including proliferation, migration, collagen gel contraction and wound healing. The effects of N/OFQ administrationin vivowere studied in ovalbumin (OVA)‐sensitized and challenged mice.Key Results: NOP receptors were expressed on a wide range of human and mouse immune and airway cells. Eosinophils expressed N/OFQ‐precursor mRNA and their number correlated with N/OFQ concentration. N/OFQ was found in human sputum and increased in asthma. Additionally, in asthmatic human lungs N/OFQ immunoreactivity was elevated. NOP receptor activation inhibited migration of immunocytes and increased wound healing in airway structural cells. Furthermore, N/OFQ relaxed spasmogen‐stimulated gel contraction. Remarkably, these findings were mirrored in OVA‐mice where N/OFQ treatment before or during sensitization substantially reduced airway constriction and immunocyte trafficking to the lung, in particular eosinophils. N/OFQ also reduced inflammatory mediators and mucin production.Conclusions and Implications: We demonstrated a novel dual airway immunomodulator/bronchodilator role for N/OFQ and suggest targeting this system as an innovative treatment for asthma.
- Open Access
- 10 February 2016
- Published by Taylor & Francis in Cogent Engineering
- Vol. 3 (1)
A review on future planar transmission line
Substrate Integrated Waveguide (SIW) is an emerging trend in planar technology. The SIW structure consists of two rows of conducting cylinders in a dielectric substrate. The average power-handling capacity of an SIW structure is primarily determined by its substrate materials and its geometric topology. The power-handling capability depends on the nature of SIW circuits. Microwave and millimeter wave components can be integrated on SIW. It acts as a bridge between planar and non-planar technology. By using innovative fabrication techniques, SIW technology combines the classical planar circuits and metallic waveguide. The animus of the study is to provide the idea on design and fabrication of SIW structures and comparison between different topologies used for size reduction and dominant mode bandwidth enhancement
- 10 February 2016
- Published by Taylor & Francis in Cogent Engineering
- Vol. 3 (1)
Open AccessA review on future planar transmission line
Substrate Integrated Waveguide (SIW) is an emerging trend in planar technology. The SIW structure consists of two rows of conducting cylinders in a dielectric substrate. The average power-handling capacity of an SIW structure is primarily determined by its substrate materials and its geometric topology. The power-handling capability depends on the nature of SIW circuits. Microwave and millimeter wave components can be integrated on SIW. It acts as a bridge between planar and non-planar technology. By using innovative fabrication techniques, SIW technology combines the classical planar circuits and metallic waveguide. The animus of the study is to provide the idea on design and fabrication of SIW structures and comparison between different topologies used for size reduction and dominant mode bandwidth enhancement
- Open Access
CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration
Background: Asthma is characterized by variable airflow obstruction, airway inflammation, airway hyper‐responsiveness and airway remodelling. Airway smooth muscle (ASM) hyperplasia is a feature of airway remodelling and contributes to bronchial wall thickening. We sought to investigate the expression levels of chemokines in primary cultures of ASM cells from asthmatics vs healthy controls and to assess whether differentially expressed chemokines (i) promote fibrocyte (FC) migration towards ASM and (ii) are increased in blood from subjects with asthma and in sputum samples from those asthmatics with bronchial wall thickening.Methods: Chemokine concentrations released by primary ASM were measured by MesoScale Discovery platform. The chemokine most highly expressed by ASM from asthmatics compared with healthy controls was confirmed by ELISA, and expression of its cognate chemokine receptor by FCs was examined by immunofluorescence and flow cytometry. The role of this chemokine in FC migration towards ASM was investigated by chemotaxis assays.Results: Chemokine (C‐C motif) ligand 2 (CCL2) levels were increased in primary ASM supernatants from asthmatics compared with healthy controls. CCR2 was expressed on FCs. Fibrocytes migrated towards recombinant CCL2 and ASM supernatants. These effects were inhibited by CCL2 neutralization. CCL2 levels were increased in blood from asthmatics compared with healthy controls, and sputum CCL2 was increased in asthmatics with bronchial wall thickening.Conclusions: Airway smooth muscle‐derived CCL2 mediates FC migration and potentially contributes to the development of ASM hyperplasia in asthma.
Open AccessCCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration
Background: Asthma is characterized by variable airflow obstruction, airway inflammation, airway hyper‐responsiveness and airway remodelling. Airway smooth muscle (ASM) hyperplasia is a feature of airway remodelling and contributes to bronchial wall thickening. We sought to investigate the expression levels of chemokines in primary cultures of ASM cells from asthmatics vs healthy controls and to assess whether differentially expressed chemokines (i) promote fibrocyte (FC) migration towards ASM and (ii) are increased in blood from subjects with asthma and in sputum samples from those asthmatics with bronchial wall thickening.Methods: Chemokine concentrations released by primary ASM were measured by MesoScale Discovery platform. The chemokine most highly expressed by ASM from asthmatics compared with healthy controls was confirmed by ELISA, and expression of its cognate chemokine receptor by FCs was examined by immunofluorescence and flow cytometry. The role of this chemokine in FC migration towards ASM was investigated by chemotaxis assays.Results: Chemokine (C‐C motif) ligand 2 (CCL2) levels were increased in primary ASM supernatants from asthmatics compared with healthy controls. CCR2 was expressed on FCs. Fibrocytes migrated towards recombinant CCL2 and ASM supernatants. These effects were inhibited by CCL2 neutralization. CCL2 levels were increased in blood from asthmatics compared with healthy controls, and sputum CCL2 was increased in asthmatics with bronchial wall thickening.Conclusions: Airway smooth muscle‐derived CCL2 mediates FC migration and potentially contributes to the development of ASM hyperplasia in asthma.